Navigation Links
Researchers find new mechanism behind the formation and maintenance of long-term memories

Researchers from Mount Sinai School of Medicine have found that lactate, a type of energy fuel in the brain, plays a critical role in the formation of long-term memory. These findings have important implications for common illnesses like Alzheimer's disease, other neurodegenerative disorders, aging-related memory impairment and diabetes. The research is published in the March 4th issue of the journal Cell.

The study is the first to closely evaluate the role of lactate and the effect of its transport from astrocytesa subtype of brain cellsto neurons in long-term memory in mammals, said lead researcher Cristina Alberini, PhD, Professor of Neuroscience at Mount Sinai School of Medicine. "Little is known about the role of astrocytes in cognitive functions. The results further prove that astrocytes are much more actively involved in memory formation than previously thought, and that lactate is a promising target for investigating novel mechanisms that may be the cause of deficits of long-term memories." The data have potential significant implications in understanding and treating diseases like Alzheimer's, dementia, and diabetes, she said.

Researchers historically have believed that the brain cells called astrocytes only played a supportive role to neurons and had no major roles in higher brain functions. As a result, research on the development of long-term memory has largely focused on neurons. However, in recent years, data have shown that astrocytes are more involved than previously thought. Working with this evidence, Dr. Alberini and her team found that lactate released by astrocytes has a critical function in long-term memory development.

Astrocytes but not neurons contain glycogen, the storage form of glucose. Dr. Alberini's research supports a previous hypothesis that lactate produced by astrocytes provides fuel to neurons, and shows that lactate in the brain is elevated during long-term memory formation.

The researchers injected into the brains of rats an amnesic compound that blocks glycogenolysis (the breakdown of glycogen), and prevented the learning-dependent release of lactate. They did this both before and after "inhibitory avoidance learning," in which the rats learn to avoid a place where they previously had an unpleasant experience. They also injected some rats with both the amnesic compound and lactate.

The researchers found that the rats that were injected with the compound only, either before or after the unpleasant experience, had significantly impaired long-term memory. However, lactate together with the blocking compound served to "rescue" or reduce memory loss. Short-term memory and learning were not impacted by the presence of the amnestic compound or lactate.

Since it is known that glucose is an important energy source and can modulate memory retention, Dr. Alberini's team wanted to see if similar benefits were achieved by using glucose rather than lactate in the study. They injected glucose in amounts equicaloric to the lactate used in the first study into the brains of rats that also received the amnesic compound before inhibitory avoidance training. The researchers saw no rescue effect on long-term memory but after increasing the dose of glucose by three times, they saw a positivethough transientimpact.

"These results show that when a lot of energy is required, such as in long-term memory formation, glucose is not sufficient, or is less efficient, for long-term formation and maintenance," said Dr. Alberini. "Now that we know that lactate has this critical function, we can study why it does and why glucose does not have the same impact."

Dr. Alberini and her team plan to further study the role of lactate in long-term memory formation to find how it can be used as a potential target for neurodegenerative diseases. This study is supported by a grant from the National Institute of Mental Health.


Contact: Mount Sinai Press Office
The Mount Sinai Hospital / Mount Sinai School of Medicine

Related medicine news :

1. Researchers pinpoint genetic pathways involved in breast cancer
2. Penn researchers find new role for cancer protein p53
3. UCSF researchers uncover hormone pathway to fatty liver disease
4. Researchers pinpoint patients who receive greatest benefit from heart failure treatment
5. IDIBELL researchers discover a substance against the dark genome of cancer
6. Wayne State University researchers publish results settling multiple sclerosis debate
7. E-health must be a priority, researchers say
8. Mayo Clinic researchers confirm value of therapeutic hypothermia after cardiac arrest
9. Mayo researchers, Rochester educators, students to present at science conference
10. Researchers work at the frontiers of islet cell transplantation
11. Brain Appears to Be a Task Machine, Researchers Say
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... D.C. (PRWEB) , ... November 25, 2015 , ... Today, ... fatalities on our nation’s roadways has dropped below 10,000 for the first time since ... 10,076 in 2013. , According to data released by the National Highway Traffic Safety ...
(Date:11/25/2015)... Md (PRWEB) , ... November 25, 2015 , ... ... Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for ... of this disease. The Periwinkle Pioneers, nominated by the public, will receive special ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... LLC has announced that it has undertaken significant expansion of its current state ... The investment is part of PharmaTech’s strategy to increase its manufacturing capacity as ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
(Date:11/24/2015)... Nov. 24, 2015  DILON Diagnostics and GE Healthcare ... agreement for DILON to distribute GE,s Discovery NM750b Molecular ... signing of this distribution agreement will provide Dilon,s experienced ... Imaging system and is considered an initial step in ... solutions for clinicians and their patients. ...
Breaking Medicine Technology: